Our findings in this study established that Vb and its main constituents bufalin, cinobufagin and resibufogenin significantly ameliorated RSV-induced pulmonary tissue damage in mice while reducing viral gene and pro-inflammatory cytokines expression, and enhancing the expression of type I interferons (IFN-α/β) to combat viral infection. Here, IFNA1 is linked to viral infectious disease.